IRIX Iridex Corp.

Iridex to Participate in Fireside Chat with Stifel Equity Research

Iridex to Participate in Fireside Chat with Stifel Equity Research

MOUNTAIN VIEW, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in a fireside chat with its covering equity research analyst from Stifel.

Management is scheduled to discuss the business on Thursday, December 8, 2022 at 9:00 a.m. PT / 12:00 p.m. ET. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at: .

About Iridex

Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit .

Investor Relations Contact:

Philip Taylor

(415) 937-5406



EN
06/12/2022

Underlying

IRIXIridex Corp.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Iridex Corp.

 PRESS RELEASE
Free
IRIX IRIDEX CORP.

Iridex Announces First Patient Enrolled in an Independent Landmark Inv...

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, announced today that the first patient has been successfully enrolled in the independent, investigator-led DAME Trial to evaluate the clinical ef...

June 24, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
MMLP Martin Midstrea...
MERC Mercer Internat... ... (+13)

InsiderInsights.com Daily Ratings Report: June 13, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

MMLP MARTIN MIDSTREAM PARTNERS L.P.
MERC MERCER INTERNATIONAL INC.
FFIN FIRST FINANCIAL BANKSHARES INC
CABO CABLE ONE INC.
BUSE FIRST BUSEY CORPORATION
IRIX IRIDEX CORP.
ADC AGREE REALTY CORPORATION
TTI TETRA TECHNOLOGIES INC.
VRA VERA BRADLEY INC.
QTRX QUANTERIX CORPORATION
ULBI ULTRALIFE
DCTH DELCATH SYSTEMS
WHLR WHEELER REAL ESTATE INVESTMENT TRUST INC.
06/14/25 June 14, 2025 1 EN
 PRESS RELEASE
Free
IRIX IRIDEX CORP.

Iridex Reports First Quarter 2025 Financial Results

Iridex Reports First Quarter 2025 Financial Results MOUNTAIN VIEW, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the first quarter ended March 29, 2025. First Quarter 2025 Financial Highlights Total revenue was $11.9 million, compared to $11.8 million in the first quarter of 2024Cyclo G6® product family revenue was $3.2 million, an increase of 8%...

May 13, 2025 1 EN
Free Trial
IRIX IRIDEX CORP.

Iridex Corp: 2 directors

A director at Iridex Corp bought 20,000 shares at 1.207USD and the significance rating of the trade was 38/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

05/01/25 May 1, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
LUV SOUTHWEST AIRLI...
TBK Triumph Bancorp... ... (+12)

InsiderInsights.com Daily Ratings Report: April 30, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

LUV SOUTHWEST AIRLINES CO.
TBK TRIUMPH BANCORP INC.
NBTB NBT BANCORP INC.
MTDR MATADOR RESOURCES COMPANY
IRIX IRIDEX CORP.
SNWV SANUWAVE HEALTH
OVLY OAK VALLEY BANCORP
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
FNLC FIRST BANCORP
DLHC INC (ME)
SUNS DALEIGH HOLDINGS CORP
SUNRISE REALTY TRUST
05/01/25 May 1, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch